• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过人乳腺癌异种移植瘤的局部(31)P磁共振波谱在体内定量胆碱代谢物对多西他赛治疗的反应,并通过细胞提取物的高分辨率(31)P核磁共振波谱在体外进行定量。

Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.

作者信息

Morse David L, Raghunand Natarajan, Sadarangani Pooja, Murthi Shiva, Job Constantin, Day Sam, Howison Christine, Gillies Robert J

机构信息

The University of Arizona, BIO5 Institute, Arizona Cancer Center, Tucson, Arizona 85724, USA.

出版信息

Magn Reson Med. 2007 Aug;58(2):270-80. doi: 10.1002/mrm.21333.

DOI:10.1002/mrm.21333
PMID:17654590
Abstract

Choline-containing compounds (CCCs) are elevated in breast cancer, and detected in vivo by the (1)H MRS total choline (tCho) resonance (3.25 ppm) and the (31)P MRS phosphomonoester (PME) resonance (3.8 ppm). Both the tCho and PME resonances decrease early after initiation of successful therapy. The single major component of these composite resonances, phosphocholine (PCho), also responds to therapy by decreasing. The ability to resolve and quantify PCho in vivo would thus increase the sensitivity of this biomarker for early detection of therapeutic response. Herein, the in vivo resolution and quantification of PCho is reported in human mouse xenograft tumors of the human breast cancer cell lines MCF-7 and MDA-mb-231. Significant decreases in tumor PCho are observed within 2 to 4 d posttreatment with the antimicrotubule drug, docetaxel. To determine whether these decreases are a general tumor response or an intracellular metabolic response, high-resolution NMR spectroscopy was performed on extracts of cells treated with docetaxel. Significant decreases in intracellular PCho and increases in glycerophosphocholine (GPC) were observed. These decreases are coincident with other tumor and cellular responses such as tumor growth delay (TGD), cell-cycle arrest, and modes of cell death such as mitotic catastrophe, necrosis, and apoptosis, with mitotic catastrophe predominating.

摘要

含胆碱化合物(CCCs)在乳腺癌中含量升高,可通过氢质子磁共振波谱(1H MRS)中的总胆碱(tCho)共振峰(3.25 ppm)和磷磁共振波谱(31P MRS)中的磷酸单酯(PME)共振峰(3.8 ppm)在体内检测到。在成功治疗开始后早期,tCho和PME共振峰均下降。这些复合共振峰的单一主要成分磷酸胆碱(PCho)也会因治疗而下降。因此,在体内解析和定量PCho的能力将提高这种生物标志物对治疗反应早期检测的敏感性。本文报道了在人乳腺癌细胞系MCF-7和MDA-mb-231的人鼠异种移植瘤中PCho的体内解析和定量情况。在用抗微管药物多西他赛治疗后2至4天内,观察到肿瘤PCho显著下降。为了确定这些下降是一般的肿瘤反应还是细胞内代谢反应,对用多西他赛处理的细胞提取物进行了高分辨率核磁共振波谱分析。观察到细胞内PCho显著下降,甘油磷酸胆碱(GPC)增加。这些下降与其他肿瘤和细胞反应如肿瘤生长延迟(TGD)、细胞周期停滞以及细胞死亡模式如有丝分裂灾难、坏死和凋亡同时发生,其中有丝分裂灾难占主导。

相似文献

1
Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.通过人乳腺癌异种移植瘤的局部(31)P磁共振波谱在体内定量胆碱代谢物对多西他赛治疗的反应,并通过细胞提取物的高分辨率(31)P核磁共振波谱在体外进行定量。
Magn Reson Med. 2007 Aug;58(2):270-80. doi: 10.1002/mrm.21333.
2
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.通过磁共振波谱(MRS)和胆碱途径中的定量基因表达谱分析对乳腺癌及其治疗反应进行表征。
NMR Biomed. 2009 Jan;22(1):114-27. doi: 10.1002/nbm.1318.
3
Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.使用 DCE-MRI、离体 HRMAS 和体内 1H MRS 评估人乳腺癌实验模型中的早期多西紫杉醇反应。
NMR Biomed. 2010 Jan;23(1):56-65. doi: 10.1002/nbm.1426.
4
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.患者来源的乳腺癌异种移植模型中胆碱代谢物与基因的相互作用
Breast Cancer Res. 2014 Jan 21;16(1):R5. doi: 10.1186/bcr3597.
5
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.胆碱激酶抑制剂MN58b在人类癌症模型中的无创磁共振波谱药效学标志物
Cancer Res. 2006 Jan 1;66(1):427-34. doi: 10.1158/0008-5472.CAN-05-1338.
6
Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy.采用³¹P编辑¹H核磁共振波谱法定量测定磷酸胆碱和甘油磷酸胆碱。
NMR Biomed. 2005 Nov;18(7):413-20. doi: 10.1002/nbm.973.
7
Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.用于检测乳腺癌异种移植瘤对PI3K/mTOR抑制反应的定量(31)P高分辨魔角旋转磁共振波谱分析
Magn Reson Med. 2014 Jun;71(6):1973-81. doi: 10.1002/mrm.24869. Epub 2013 Jul 22.
8
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.17-烯丙氨基-17-去甲氧基格尔德霉素治疗导致磁共振波谱检测到胆碱代谢物升高,与胆碱转运蛋白 SLC44A1 和磷脂酶 A2 的表达增加有关。
Breast Cancer Res. 2010;12(5):R84. doi: 10.1186/bcr2729. Epub 2010 Oct 14.
9
Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.体内和体外磁共振波谱研究PX-478抑制HIF-1α后HT-29异种移植瘤中的代谢物变化。
NMR Biomed. 2005 Nov;18(7):430-9. doi: 10.1002/nbm.977.
10
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells.组蛋白去乙酰化酶抑制诱导 MCF7 乳腺癌细胞中胆碱摄取增加和磷酸胆碱水平升高。
PLoS One. 2013 Apr 23;8(4):e62610. doi: 10.1371/journal.pone.0062610. Print 2013.

引用本文的文献

1
Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.临床表型与代谢组学的整合促进了肺癌的精准医疗。
Cell Biol Toxicol. 2024 May 1;40(1):25. doi: 10.1007/s10565-024-09861-w.
2
Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells.磷脂酰胆碱衍生的脂质介质:癌细胞与免疫细胞的串扰。
Front Immunol. 2022 Feb 15;13:768606. doi: 10.3389/fimmu.2022.768606. eCollection 2022.
3
Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas.
BRAF 突变的维莫非尼敏感和耐药黑色素瘤对 BRAF 和 MEK 联合抑制反应的成像标志物
Oncotarget. 2018 Mar 30;9(24):16832-16846. doi: 10.18632/oncotarget.24709.
4
Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.阿霉素对乳腺癌胆碱代谢的分子效应
Neoplasia. 2017 Aug;19(8):617-627. doi: 10.1016/j.neo.2017.05.004. Epub 2017 Jun 24.
5
Targeting Phospholipid Metabolism in Cancer.靶向癌症中的磷脂代谢
Front Oncol. 2016 Dec 27;6:266. doi: 10.3389/fonc.2016.00266. eCollection 2016.
6
Probing the PI3K/Akt/mTor pathway using P-NMR spectroscopy: routes to glycogen synthase kinase 3.用 P-NMR 光谱探测 PI3K/Akt/mTOR 通路:通往糖原合成酶激酶 3 的途径。
Sci Rep. 2016 Nov 4;6:36544. doi: 10.1038/srep36544.
7
Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients.评估扩散加权成像(DWI)和磁共振波谱(MRS)作为宫颈癌患者早期反应生物标志物的情况。
Radiol Med. 2016 Nov;121(11):838-846. doi: 10.1007/s11547-016-0665-y. Epub 2016 Jul 2.
8
CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response.化学交换饱和转移磁共振成像(CEST-MRI)可检测到因乳腺癌细胞侵袭性和化疗反应而改变的代谢物水平。
NMR Biomed. 2016 Jun;29(6):806-16. doi: 10.1002/nbm.3526. Epub 2016 Apr 21.
9
Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy.胆碱代谢物水平升高是 BRCA1 突变型鼠乳腺肿瘤多西紫杉醇治疗反应的早期标志物:体外质子磁共振波谱评估。
J Transl Med. 2015 Apr 9;13:114. doi: 10.1186/s12967-015-0458-4.
10
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.患者来源的乳腺癌异种移植模型中胆碱代谢物与基因的相互作用
Breast Cancer Res. 2014 Jan 21;16(1):R5. doi: 10.1186/bcr3597.